<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PMJ</journal-id>
<journal-id journal-id-type="hwp">sppmj</journal-id>
<journal-id journal-id-type="nlm-ta">Palliat Med</journal-id>
<journal-title>Palliative Medicine</journal-title>
<issn pub-type="ppub">0269-2163</issn>
<issn pub-type="epub">1477-030X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269216311409474</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269216311409474</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An observational study to determine the prevalence of alcohol use disorders in advanced cancer patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Webber</surname><given-names>Katherine</given-names></name>
</contrib>
<aff id="aff1-0269216311409474">Royal Marsden NHS Hospitals Trust, UK</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Davies</surname><given-names>Andrew N</given-names></name>
</contrib>
<aff id="aff2-0269216311409474">Royal Surrey County Hospital NHS Trust, Guildford, UK</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0269216311409474">Katherine Webber, Department of Palliative Medicine, Royal Marsden Hospital, Downs Road, Sutton, SM2 5PT, UK Email: <email>kath.webber@rmh.nhs.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>4</issue>
<fpage>360</fpage>
<lpage>367</lpage>
<permissions>
<copyright-statement>© The Author(s) 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><bold>Context:</bold> observational studies in North America suggest alcohol dependence is a common problem in advanced cancer patients and is associated with a high burden of physical and psychological symptoms. The prevalence of all types of alcohol use disorders, and the relationship between alcohol use disorders and symptoms, has not been studied.</p>
<p><bold>Objectives:</bold> this observational, cross-sectional study was designed to determine the prevalence of alcohol use disorders in patients with advanced cancer and establish if such patients have a higher symptom burden.</p>
<p><bold>Methods:</bold> sequential patients referred to the palliative medicine team at a United Kingdom cancer centre completed the Alcohol Use Disorders Identification Test, Hospital Anxiety and Depression Scale (HADS) and Memorial Symptom Assessment Scale-Short Form (MSAS-SF).</p>
<p><bold>Results:</bold> 120 patients participated in the study. Twenty-two (18%) patients screened positively for the presence of an alcohol use disorder. This study found no significant association between alcohol use disorders and the presence of anxiety (<italic>P</italic> = 0.38) or depression (<italic>P</italic> = 0.81) on the HADS or the global distress index subscale (<italic>P</italic> = 0.142), physical symptom distress index subscale (<italic>P</italic> = 0.734), or the psychological distress index subscale (<italic>P</italic> = 0.154) on the MSAS-SF. Current smoking status was the only independent predictor for the presence of an alcohol use disorder (<italic>P</italic> &lt; 0.001). Seven (6%) patients screened positively for high-risk alcohol use disorders. Current smoking status (<italic>P</italic> &lt; 0.001) and male gender (<italic>p</italic> &lt; 0.001) were independent predictors of this problem.</p>
<p><bold>Conclusions:</bold> alcohol use disorders in this cohort of patients were not associated with a higher symptom burden, and the prevalence was lower than the general United Kingdom population.</p>
</abstract>
<kwd-group>
<kwd>alcohol</kwd>
<kwd>alcohol-related disorders</kwd>
<kwd>alcoholism</kwd>
<kwd>neoplasms</kwd>
<kwd>palliative care</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sectiontion1-0269216311409474" sec-type="intro">
<title>Introduction</title>
<p>Alcohol use disorders refer to the variety of health and social consequences encountered as a result of drinking alcohol,<sup><xref ref-type="bibr" rid="bibr1-0269216311409474">1</xref>,<xref ref-type="bibr" rid="bibr2-0269216311409474">2</xref></sup> including alcohol dependence, harmful use and hazardous drinking. Alcohol dependence refers to a maladaptive pattern of alcohol use consisting of at least three of the following: tolerance, withdrawal, impaired control, preoccupation with alcohol, compulsion to drink and persistent use despite harm.<sup><xref ref-type="bibr" rid="bibr3-0269216311409474">3</xref></sup> Harmful use refers to alcohol use that results in consequences to physical or mental health.<sup><xref ref-type="bibr" rid="bibr3-0269216311409474">3</xref></sup> Finally, hazardous drinking is a pattern of alcohol consumption that increases the risk of harmful consequences for the user despite the absence of the aforementioned disorders.<sup><xref ref-type="bibr" rid="bibr1-0269216311409474">1</xref></sup></p>
<p>Alcohol use disorders are common amongst the general adult population in the United Kingdom (UK) and many other parts of the world.<sup><xref ref-type="bibr" rid="bibr4-0269216311409474">4</xref>,<xref ref-type="bibr" rid="bibr5-0269216311409474">5</xref></sup> Thus, 24% of adults meet the criteria for alcohol use disorders in the UK, whilst 4% of individuals meet the criteria for alcohol dependence.<sup><xref ref-type="bibr" rid="bibr5-0269216311409474">5</xref></sup> Alcohol use disorders can have a significant burden on the individual, their family and society in general.<sup><xref ref-type="bibr" rid="bibr2-0269216311409474">2</xref></sup> In particular, alcohol use disorders are associated with increased morbidity (i.e. physical problems, psychological/psychiatric problems), impaired quality of life and increased use of healthcare services.<sup><xref ref-type="bibr" rid="bibr4-0269216311409474">4</xref>–<xref ref-type="bibr" rid="bibr7-0269216311409474">7</xref></sup></p>
<p>Studies from North America suggest relatively high levels (14%–38%) of alcohol dependence in palliative care patients with advanced cancer<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>–<xref ref-type="bibr" rid="bibr12-0269216311409474">12</xref></sup> and a higher burden of symptoms in such patients.<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>,<xref ref-type="bibr" rid="bibr13-0269216311409474">13</xref></sup> There is no analogous data from the UK, or indeed data on the prevalence of other types of alcohol use disorders from North America (or the UK). Independent predictors of alcohol use disorders in advanced cancer populations have not been studied. Thus, the aims of this study were: (1) to determine the prevalence of alcohol use disorders in palliative care patients with advanced cancer attending a cancer centre in the UK; (2) to determine if there is a relationship between alcohol use disorders and physical and psychological symptom burden; and (3) to determine if there are any independent predictors for the presence of an alcohol use disorder.</p>
</sec>
<sec id="sectiontion2-0269216311409474" sec-type="methods">
<title>Methods</title>
<sec id="sectiontion3-0269216311409474">
<title>Design and sample</title>
<p>This was an observational cross-sectional survey conducted at the Royal Marsden Hospital Cancer Centre (UK). The Royal Marsden Committee for Clinical Research and Royal Marsden Research Ethics Committee approved the study. The study was sponsored by the Royal Marsden National Health Service (NHS) Foundation Trust, and funded by the Palliative Medicine Research Fund. The Royal Marsden Hospital is a tertiary cancer centre in the UK that operates on two sites: Chelsea and Sutton. This study was conducted solely on the Sutton campus. The Royal Marsden Hospital Sutton Palliative Care Department consists of a hospital support team, which receives inpatient and outpatient referrals from oncology and haematology departments, and a palliative care inpatient unit, which accepts patients for complex symptom control and end-of-life care. Often patients are initially referred to the hospital support team and then transferred to the inpatient unit, but direct new referrals to the inpatient unit also occur. The inpatient unit has a wide range of patients who may also be having active treatment and be under joint care with oncology teams.</p>
<p>Subjects were considered eligible for the study if they were new referrals to the Royal Marsden Hospital Palliative Care Department (Sutton), hospital support team or inpatient unit, from 1 May 2008. Every new referral seen in the inpatient or outpatient department by any member of the Palliative Care Team was approached about the study if they met the inclusion criteria.</p>
<p>The inclusion criteria were: (a) diagnosis of advanced cancer (could be having palliative chemotherapy or radiotherapy, or no active anti-cancer treatment); (b) referral to Royal Marsden Hospital palliative care team (hospital support team or inpatient unit); (c) ability to provide informed consent; (d) ability to complete the study proforma.</p>
<p>A sample size of 120 was required to detect the prevalence of an alcohol use disorder with a 95% confidence interval of width 20% or less. Recruitment continued until 120 patients had completed the study.</p>
</sec>
<sec id="sectiontion4-0269216311409474">
<title>Instruments</title>
<p>Demographic data were collected from the electronic patient record, and the subjects were asked to complete the Alcohol Use Disorders Identification Test (AUDIT),<sup><xref ref-type="bibr" rid="bibr14-0269216311409474">14</xref>–<xref ref-type="bibr" rid="bibr16-0269216311409474">16</xref></sup> the Hospital Anxiety and Depression Scale (HADS)<sup><xref ref-type="bibr" rid="bibr17-0269216311409474">17</xref>–<xref ref-type="bibr" rid="bibr18-0269216311409474">18</xref></sup> and the Memorial Symptom Assessment Scale-Short Form (MSAS-SF).<sup><xref ref-type="bibr" rid="bibr19-0269216311409474">19</xref></sup></p>
<p>The AUDIT is a 10-item screening tool developed by the World Health Organization for the detection of alcohol use disorders (i.e. hazardous consumption, harmful use and alcohol dependence). Research has consistently confirmed the validity of the English version in primary care and hospital populations, with sensitivities and specificities generally exceeding other screening methods for detecting alcohol use disorders.<sup><xref ref-type="bibr" rid="bibr14-0269216311409474">14</xref>–<xref ref-type="bibr" rid="bibr16-0269216311409474">16</xref></sup> Each item is scored on a scale from 0 to 4, giving a maximum score of 40. A score of ≥8 is the standard cut-off point for all alcohol use disorders.<sup><xref ref-type="bibr" rid="bibr14-0269216311409474">14</xref></sup> A patient is at risk of major harm from their level of alcohol consumption, and has a probable diagnosis of harmful use or dependence, if they score ≥16.<sup><xref ref-type="bibr" rid="bibr14-0269216311409474">14</xref></sup> These patients are referred to as having a high-risk alcohol use disorder. It should be noted that the AUDIT has not been validated in patients with advanced cancer, and, indeed, no alcohol-screening tool has been validated in this group of patients.</p>
<p>The HADS is a validated tool for identifying the presence of psychological symptoms in patients with cancer,<sup><xref ref-type="bibr" rid="bibr17-0269216311409474">17</xref></sup> and consists of an anxiety subscale with seven questions, and a depression subscale also with seven questions. Each subscale has a maximum score of 21, and the recommended cut-off score for detecting cases of anxiety/depression is ≥11.<sup><xref ref-type="bibr" rid="bibr17-0269216311409474">17</xref>,<xref ref-type="bibr" rid="bibr18-0269216311409474">18</xref></sup> The MSAS-SF is a validated screening tool for identifying the presence of, and distress caused by, 32 physical and psychological symptoms in patients with cancer.<sup><xref ref-type="bibr" rid="bibr19-0269216311409474">19</xref></sup> The following validated MSAS-SF subscales can be calculated from different groups of symptoms: the global distress index (GDI) (four psychological symptoms: feeling sad, worrying, feeling irritable and feeling nervous, and six physical symptoms: lack of energy, pain, lack of appetite, feeling drowsy, constipation and dry mouth); the physical symptom distress score (PHYS) (12 physical symptoms: lack of energy, pain, lack of appetite, feeling drowsy, constipation, dry mouth, nausea, vomiting, change in taste, weight loss, feeling bloated and dizziness): the psychological symptom distress score (PSYCH) (four psychological symptoms: worrying, feeling sad, feeling nervous and feeling irritable, and two physical symptoms: difficulty sleeping and difficulty concentrating).<sup><xref ref-type="bibr" rid="bibr19-0269216311409474">19</xref></sup></p>
</sec>
<sec id="sectiontion5-0269216311409474">
<title>Statistical analysis</title>
<p>Association between demographic factors and the presence of alcohol use disorders, and between HADS subscale scores and alcohol use disorders, was assessed using the chi-squared test. The Mann–Whitney <italic>U</italic>-test and independent <italic>t</italic>-test were used to determine correlation between alcohol use disorders and the MSAS-SF subscale scores and individual symptom scores. Multivariate binary logistic regression modelling was utilized to determine independent factors that predict alcohol use disorders. All models included age, sex, smoking status, diagnosis and performance status as covariates. Continuous data was analysed using Pearson’s correlation coefficient and <italic>r</italic>-values presented (<italic>r</italic> = 1 is perfect correlation). SPSS (version 17)<sup><xref ref-type="bibr" rid="bibr20-0269216311409474">20</xref></sup> was used for statistical analysis. Significance was defined as having a <italic>P</italic> value of 0.05 or less.</p>
</sec>
</sec>
<sec id="sectiontion6-0269216311409474" sec-type="results">
<title>Results</title>
<p>One hundred and twenty patients completed the study (see <xref ref-type="table" rid="table1-0269216311409474">Table 1</xref>). Fifteen patients declined to take part in the study (seven fatigued, two refused involvement in research, six no reason given). Twenty-two (18%) patients scored ≥8 on the AUDIT (indicating the presence of an alcohol use disorder), whilst seven (6%) patients scored ≥16 on the AUDIT (indicating the presence of a high-risk alcohol use disorder, possible harmful use or dependence).</p>
<table-wrap id="table1-0269216311409474" position="float">
<label>Table 1.</label>
<caption><p>Demographic information</p></caption>
<graphic alternate-form-of="table1-0269216311409474" xlink:href="10.1177_0269216311409474-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristics</th>
<th align="left">Frequency (<italic>n</italic> = 120)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>Median 61 yr (range 20–87 yr)</td>
</tr>
<tr>
<td>Sex</td>
<td/>
</tr>
<tr>
<td> Female</td>
<td>65 (54%)</td>
</tr>
<tr>
<td> Male</td>
<td>55 (46%)</td>
</tr>
<tr>
<td>ECOG performance status</td>
<td/>
</tr>
<tr>
<td> 0</td>
<td>3 (2%)</td>
</tr>
<tr>
<td> 1</td>
<td>32 (27%)</td>
</tr>
<tr>
<td> 2</td>
<td>38 (32%)</td>
</tr>
<tr>
<td> 3</td>
<td>43 (36%)</td>
</tr>
<tr>
<td> 4</td>
<td>4 (3%)</td>
</tr>
<tr>
<td>Cancer diagnosis</td>
<td/>
</tr>
<tr>
<td> Gastro-intestinal</td>
<td>33 (28%)</td>
</tr>
<tr>
<td> Breast</td>
<td>17 (14%)</td>
</tr>
<tr>
<td> Lung</td>
<td>16 (13%)</td>
</tr>
<tr>
<td> Urological</td>
<td>16 (13%)</td>
</tr>
<tr>
<td> Haemato-oncological</td>
<td>12 (10%)</td>
</tr>
<tr>
<td> Gynaecological</td>
<td>10 (8%)</td>
</tr>
<tr>
<td> Head and neck</td>
<td>8 (7%)</td>
</tr>
<tr>
<td> Other</td>
<td>8 (7%)</td>
</tr>
<tr>
<td>Smoking status</td>
<td/>
</tr>
<tr>
<td> Never smoked</td>
<td>49 (41%)</td>
</tr>
<tr>
<td> Ex-smoker</td>
<td>50 (42%)</td>
</tr>
<tr>
<td> Current smoker</td>
<td>21 (17%)</td>
</tr>
<tr>
<td>Patient location</td>
<td/>
</tr>
<tr>
<td> Inpatient</td>
<td>104 (87%)</td>
</tr>
<tr>
<td> Outpatient</td>
<td>16 (13%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269216311409474">
<p>ECOG: Eastern Cooperative Oncology Group</p></fn>
</table-wrap-foot>
</table-wrap>
<p>This study showed a significant association between alcohol use disorders and current smoking status (<italic>P</italic> &lt; 0.001), as well as a diagnosis of head and neck cancer (<italic>P</italic> = 0.002). This study showed no significant association between alcohol use disorders and age (<italic>p</italic> = 0.151) or Eastern Cooperative Oncology Group (ECOG) performance status (<italic>p</italic> = 0.09). See <xref ref-type="table" rid="table2-0269216311409474">Table 2</xref>.</p>
<table-wrap id="table2-0269216311409474" position="float">
<label>Table 2.</label>
<caption><p>Associations between alcohol use disorders and demographics</p></caption>
<graphic alternate-form-of="table2-0269216311409474" xlink:href="10.1177_0269216311409474-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="left"><italic>N</italic></th>
<th align="left">AUDIT &lt; 8 <italic>N</italic> = 98</th>
<th align="left">AUDIT ≥ 8<sup><xref ref-type="table-fn" rid="table-fn2-0269216311409474">a</xref></sup> <italic>N</italic> = 22</th>
<th align="left"><italic>P</italic> value</th>
<th align="left"><italic>N</italic></th>
<th align="left">AUDIT &lt; 16 <italic>N</italic> = 113</th>
<th align="left">AUDIT ≥ 16<sup><xref ref-type="table-fn" rid="table-fn2-0269216311409474">b</xref></sup> <italic>N</italic> = 7</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="4" valign="top">Gender</td>
<td rowspan="2" valign="top">Male</td>
<td>55</td>
<td>41</td>
<td>14</td>
<td rowspan="4" valign="top">0.064 (chi-squared)</td>
<td>55</td>
<td>48</td>
<td>7</td>
<td rowspan="4" valign="top">0.003</td>
</tr>
<tr>
<td>100%</td>
<td>75%</td>
<td>25%</td>
<td>100%</td>
<td>87%</td>
<td>13%</td>
</tr>
<tr>
<td rowspan="2" valign="top">Female</td>
<td>65</td>
<td>57</td>
<td>8</td>
<td>65</td>
<td>65</td>
<td>0</td>
</tr>
<tr>
<td>100%</td>
<td>88%</td>
<td>12%</td>
<td>100%</td>
<td>100%</td>
<td>0%</td>
</tr>
<tr>
<td rowspan="4" valign="top">Smoking status</td>
<td rowspan="2" valign="top">Never smoked</td>
<td>49</td>
<td>46</td>
<td>3</td>
<td rowspan="4" valign="top">0.004 (chi-squared)</td>
<td>49</td>
<td>49</td>
<td>0</td>
<td rowspan="4" valign="top">0.024</td>
</tr>
<tr>
<td>100%</td>
<td>94%</td>
<td>6%</td>
<td>100%</td>
<td>100%</td>
<td>0%</td>
</tr>
<tr>
<td rowspan="2" valign="top">Smoker/ex-smoker</td>
<td>71</td>
<td>52</td>
<td>19</td>
<td>71</td>
<td>64</td>
<td>7</td>
</tr>
<tr>
<td>100%</td>
<td>73%</td>
<td>27%</td>
<td>100%</td>
<td>90%</td>
<td>10%</td>
</tr>
<tr>
<td>Age</td>
<td>Mean age</td>
<td>120</td>
<td>61.8 (SD 13.2)</td>
<td>57.7 (SD 8.7)</td>
<td>0.171 (<italic>t</italic>-test)</td>
<td>120</td>
<td>54.8 (SD 12.8)</td>
<td>54.9 (SD 8)</td>
<td>0.203</td>
</tr>
<tr>
<td rowspan="4" valign="top">Performance status</td>
<td rowspan="2" valign="top">ECOG 0–2</td>
<td>73</td>
<td>57</td>
<td>16</td>
<td rowspan="4" valign="top">0.206 (chi-squared)</td>
<td>73</td>
<td>66</td>
<td>7</td>
<td rowspan="4" valign="top">0.029</td>
</tr>
<tr>
<td>100%</td>
<td>78%</td>
<td>22%</td>
<td>100%</td>
<td>90%</td>
<td>10%</td>
</tr>
<tr>
<td rowspan="2" valign="top">ECOG 3–4</td>
<td>47</td>
<td>41</td>
<td>6</td>
<td>47</td>
<td>47</td>
<td>0</td>
</tr>
<tr>
<td>100%</td>
<td>87%</td>
<td>13%</td>
<td>100%</td>
<td>100%</td>
<td>0%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0269216311409474">
<label>a, b</label>
<p>AUDIT (Alcohol Use Disorders Identification Test) ≥8 = positive screening for any alcohol use disorder, ≥16 = positive screening for a high-risk alcohol use disorder.</p></fn>
<fn id="table-fn3-0269216311409474">
<p>ECOG: Eastern Cooperative Oncology Group</p></fn>
</table-wrap-foot>
</table-wrap>
<p>There was a significant association between the presence of high-risk alcohol use disorders (AUDIT ≥ 16) and male gender (<italic>P</italic> = 0.003), ECOG performance status 0–2 (<italic>P</italic> = 0.029) and current smoking status (<italic>P</italic> &lt; 0.001) (<xref ref-type="table" rid="table2-0269216311409474">Table 2</xref>). There were no females or non-smokers who screened positively for a high-risk alcohol use disorder. Fifty percent of head and neck cancer patients screened positively for high-risk alcohol consumption on the AUDIT, and head and neck cancer patients represented 57% of all high-risk drinkers. This result was statistically significant (<italic>P</italic> &lt; 0.0001)</p>
<p>Current smoking status was the only independent predictor for the presence of an alcohol use disorder (<italic>P</italic> &lt; 0.001) (<xref ref-type="table" rid="table3-0269216311409474">Table 3</xref>). The independent factors that predicted high-risk alcohol use disorders were male gender (<italic>P</italic> &lt; 0.001) and current smoking status (<italic>P</italic> &lt; 0.001) (<xref ref-type="table" rid="table3-0269216311409474">Table 3</xref>).</p>
<table-wrap id="table3-0269216311409474" position="float">
<label>Table 3.</label>
<caption><p>Factors associated with the presence of an alcohol use disorder in multivariable analysis</p></caption>
<graphic alternate-form-of="table3-0269216311409474" xlink:href="10.1177_0269216311409474-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Outcome variable</th>
<th align="left">Variable</th>
<th/>
<th align="left">Adjusted odds ratio (95% CI)</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3" valign="top">Alcohol use disorder (AUDIT ≥ 8)</td>
<td rowspan="3" valign="top">Smoking status</td>
<td>Current smoker</td>
<td>Reference</td>
<td>Reference</td>
</tr>
<tr>
<td>Ex smoker</td>
<td>0.241 (0.079–0.74)</td>
<td>0.013</td>
</tr>
<tr>
<td>Never smoked</td>
<td>0.072 (0.017–0.305)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td rowspan="5" valign="top">High-risk alcohol use disorder (AUDIT ≥ 16)</td>
<td rowspan="3" valign="top">Smoking status</td>
<td>Current smoker</td>
<td>Reference</td>
<td>Reference</td>
</tr>
<tr>
<td>Ex smoker</td>
<td>0.037 (0.04–0.367)</td>
<td>0.005</td>
</tr>
<tr>
<td>Never smoked</td>
<td>No patients in this group<sup><xref ref-type="table-fn" rid="table-fn4-0269216311409474">a</xref></sup></td>
<td>&lt;0.0001</td>
</tr>
<tr>
<td rowspan="2" valign="top">Gender</td>
<td>Male</td>
<td>Reference</td>
<td/>
</tr>
<tr>
<td>Female</td>
<td>No patients in this group<sup><xref ref-type="table-fn" rid="table-fn4-0269216311409474">a</xref></sup></td>
<td>&lt;0.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0269216311409474">
<label>a</label>
<p>Odds ratio could not be calculated.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>All of the patients were experiencing numerous physical symptoms according to the MSAS-SF; the median number of reported symptoms was 15 (range 4–27). The most commonly reported symptoms were lack of energy (92%), feeling drowsy (88%) and pain (86%) (<xref ref-type="table" rid="table4-0269216311409474">Table 4</xref>). There were no significant differences in symptom distress scores between inpatients and outpatients. Patients with an alcohol use disorder, or high-risk alcohol use disorder, did not have significantly higher individual symptom distress scores. In fact, the distress caused by lack of appetite was significantly higher in patients without an alcohol use disorder (<xref ref-type="table" rid="table4-0269216311409474">Table 4</xref>).</p>
<table-wrap id="table4-0269216311409474" position="float">
<label>Table 4.</label>
<caption><p>Association between alcohol use disorders and distress scores for the most frequently reported symptoms</p></caption>
<graphic alternate-form-of="table4-0269216311409474" xlink:href="10.1177_0269216311409474-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="left">AUDIT &lt; 8 <italic>N</italic> = 98</th>
<th align="left">AUDIT ≥ 8<sup><xref ref-type="table-fn" rid="table-fn5-0269216311409474">a</xref></sup> <italic>N</italic> = 22</th>
<th align="left">Mann–Whitney <italic>P</italic> value</th>
<th align="left">AUDIT &lt; 16 <italic>N</italic> = 113</th>
<th align="left">AUDIT ≥ 16<sup><xref ref-type="table-fn" rid="table-fn5-0269216311409474">b</xref></sup> <italic>N</italic> = 7</th>
<th align="left">Mann–Whitney <italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2" valign="top">Lack of energy</td>
<td><italic>N = 110</italic></td>
<td><italic>N = 91</italic></td>
<td><italic>N = 19</italic></td>
<td/>
<td><italic>N = 104</italic></td>
<td><italic>N = 6</italic></td>
<td/>
</tr>
<tr>
<td>Mean distress score (SD)</td>
<td>2.94 (0.9)</td>
<td>2.7 (1.1)</td>
<td>0.38</td>
<td>2.87 (1.0)</td>
<td>3.33 (0.6)</td>
<td>0.28</td>
</tr>
<tr>
<td rowspan="2" valign="top">Feeling drowsy</td>
<td><italic>106</italic></td>
<td><italic>88</italic></td>
<td><italic>18</italic></td>
<td/>
<td><italic>100</italic></td>
<td><italic>6</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.5 (0.9)</td>
<td>2.4 (0.8)</td>
<td>0.62</td>
<td>2.5 (0.9)</td>
<td>2.7(0.8)</td>
<td>0.76</td>
</tr>
<tr>
<td rowspan="2" valign="top">Pain</td>
<td><italic>103</italic></td>
<td><italic>85</italic></td>
<td><italic>18</italic></td>
<td/>
<td><italic>96</italic></td>
<td><italic>7</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>3.1 (0.9)</td>
<td>3.1 (0.9)</td>
<td>0.94</td>
<td>3.1 (0.9)</td>
<td>3.4 (0.6)</td>
<td>0.41</td>
</tr>
<tr>
<td rowspan="2" valign="top">Dry mouth</td>
<td><italic>84</italic></td>
<td><italic>70</italic></td>
<td><italic>14</italic></td>
<td/>
<td><italic>79</italic></td>
<td><italic>5</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.3 (1.0)</td>
<td>2.7 (1.1)</td>
<td>0.27</td>
<td>2.4 (1.1)</td>
<td>2.7 (1.2)</td>
<td>0.51</td>
</tr>
<tr>
<td rowspan="2" valign="top">Difficulty concentrating</td>
<td><italic>83</italic></td>
<td><italic>71</italic></td>
<td><italic>12</italic></td>
<td/>
<td><italic>80</italic></td>
<td><italic>3</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.3 (0.9)</td>
<td>2.2 (0.9)</td>
<td>0.69</td>
<td>2.29 (0.9)</td>
<td>2.67 (1.2)</td>
<td>0.54</td>
</tr>
<tr>
<td rowspan="2" valign="top">Lack of appetite</td>
<td><italic>83</italic></td>
<td><italic>71</italic></td>
<td><italic>12</italic></td>
<td/>
<td><italic>79</italic></td>
<td><italic>4</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.9 (1.0)</td>
<td>2.0 (1.0)</td>
<td>0.01</td>
<td>2.73 (1.0)</td>
<td>3.0 (1.0)</td>
<td>0.68</td>
</tr>
<tr>
<td rowspan="2" valign="top">Worrying</td>
<td><italic>82</italic></td>
<td><italic>68</italic></td>
<td><italic>14</italic></td>
<td/>
<td><italic>77</italic></td>
<td><italic>5</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.51 (0.8)</td>
<td>2.64 (0.7)</td>
<td>0.45</td>
<td>2.52 (0.8)</td>
<td>2.8 (0.4)</td>
<td>0.33</td>
</tr>
<tr>
<td rowspan="2" valign="top">Weight loss</td>
<td><italic>77</italic></td>
<td><italic>60</italic></td>
<td><italic>17</italic></td>
<td/>
<td><italic>71</italic></td>
<td><italic>6</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.6 (1.2)</td>
<td>1.9 (1.0)</td>
<td>0.044</td>
<td>2.4 (1.2)</td>
<td>2.5 (1.1)</td>
<td>0.84</td>
</tr>
<tr>
<td rowspan="2" valign="top">Feeling sad</td>
<td><italic>76</italic></td>
<td><italic>61</italic></td>
<td><italic>15</italic></td>
<td/>
<td><italic>71</italic></td>
<td><italic>5</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.2 (0.7)</td>
<td>2.12 (0.7)</td>
<td>0.94</td>
<td>2.17 (0.7)</td>
<td>2.4 (0.9)</td>
<td>0.36</td>
</tr>
<tr>
<td rowspan="2" valign="top">Change in the way food tastes</td>
<td><italic>74</italic></td>
<td><italic>64</italic></td>
<td><italic>10</italic></td>
<td/>
<td><italic>71</italic></td>
<td><italic>3</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.5 (1.0)</td>
<td>2.1 (1.0)</td>
<td>0.17</td>
<td>2.47</td>
<td>2.13</td>
<td>0.55</td>
</tr>
<tr>
<td rowspan="2" valign="top">Constipation</td>
<td><italic>71</italic></td>
<td><italic>58</italic></td>
<td><italic>13</italic></td>
<td/>
<td><italic>68</italic></td>
<td><italic>3</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>3.0 (1.0)</td>
<td>2.7 (1.0)</td>
<td>0.42</td>
<td>2.87 (1.0)</td>
<td>3.73 (0.5)</td>
<td>0.14</td>
</tr>
<tr>
<td rowspan="2" valign="top">Nausea</td>
<td><italic>70</italic></td>
<td><italic>61</italic></td>
<td><italic>9</italic></td>
<td/>
<td><italic>68</italic></td>
<td><italic>2</italic></td>
<td/>
</tr>
<tr>
<td/>
<td>2.8 (1.0)</td>
<td>2.8 (0.8)</td>
<td>0.86</td>
<td>2.77 (0.1)</td>
<td>3.6 (0.6)</td>
<td>0.24</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0269216311409474">
<label>a, b</label>
<p>AUDIT (Alcohol Use Disorders Identification Test) ≥ 8 = positive screening for any alcohol use disorder, ≥16 = positive screening for a high-risk alcohol use disorder.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>This study showed no significant association between the presence of an alcohol use disorder and the MSAS-SF total score (<italic>P</italic> = 0.865), GDI subscale (<italic>P</italic> = 0.142), physical symptom distress subscale (<italic>P</italic> = 0.734) or the psychological symptom distress subscale (<italic>P</italic> = 0.154) (<xref ref-type="table" rid="table5-0269216311409474">Table 5</xref>). Similarly, there was no significant association between the presence of an alcohol use disorder and thepresence of anxiety or depression on the HADS (<xref ref-type="table" rid="table6-0269216311409474">Table 6</xref>). When looking more specifically at high-risk alcohol use disorders (i.e. AUDIT score≥16) this study showed no correlation with the MSAS-SF subscales scores (GDI: <italic>P</italic> = 0.523; PHYS: <italic>P</italic> = 0.382; PSYCH: <italic>P</italic> = 0.63) (<xref ref-type="table" rid="table5-0269216311409474">Table 5</xref>). There was no association between the presence of a high-risk alcohol use disorder and anxiety (<italic>P</italic> = 0.949) on the Hospital Anxiety and Depression Scale Anxiety score (HADS-A) but there was a positive association between high-risk alcohol disorders and depression (<italic>P</italic> = 0.045) (<xref ref-type="table" rid="table6-0269216311409474">Table 6</xref>).</p>
<table-wrap id="table5-0269216311409474" position="float">
<label>Table 5.</label>
<caption><p>Association between alcohol use disorders and Memorial Symptom Assessment Scale-Short Form (MSAS-SF) subscales</p></caption>
<graphic alternate-form-of="table5-0269216311409474" xlink:href="10.1177_0269216311409474-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">MSAS-SF subscale</th>
<th align="left">AUDIT &lt; 8 <italic>N</italic> = 98</th>
<th align="left">AUDIT ≥ 8<sup><xref ref-type="table-fn" rid="table-fn6-0269216311409474">a</xref></sup> <italic>N</italic> = 22</th>
<th align="left">Mann–Whitney <italic>P</italic> value</th>
<th align="left">AUDIT &lt; 16 <italic>N</italic> = 113</th>
<th align="left">AUDIT ≥ 16<sup><xref ref-type="table-fn" rid="table-fn6-0269216311409474">b</xref></sup> <italic>N</italic> = 7</th>
<th align="left">Mann–Whitney <italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total<sup><xref ref-type="table-fn" rid="table-fn7-0269216311409474">c</xref></sup> mean score (SD)</td>
<td>38.3 (15.9)</td>
<td>38.9 (15.8)</td>
<td>0.865</td>
<td>38.5 (16)</td>
<td>36.9 (12)</td>
<td>0.915</td>
</tr>
<tr>
<td>GDI<sup><xref ref-type="table-fn" rid="table-fn8-0269216311409474">d</xref></sup></td>
<td>17.7 (6.4)</td>
<td>19.2 (7.1)</td>
<td>0.142</td>
<td>18 (6.5)</td>
<td>17.9 (7.8)</td>
<td>0.523</td>
</tr>
<tr>
<td>PHYS<sup><xref ref-type="table-fn" rid="table-fn9-0269216311409474">e</xref></sup></td>
<td>20.6 (8.5)</td>
<td>20.1 (10.2)</td>
<td>0.734</td>
<td>20.7 (8.9)</td>
<td>16.9 (7.6)</td>
<td>0.382</td>
</tr>
<tr>
<td>PSYCH<sup><xref ref-type="table-fn" rid="table-fn10-0269216311409474">f</xref></sup>
</td>
<td>7.6 (4.4)</td>
<td>9.1 (4.3)</td>
<td>0.154</td>
<td>7.8 (4.3)</td>
<td>8.4 (5.4)</td>
<td>0.630</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0269216311409474">
<label>a, b</label>
<p>AUDIT (Alcohol Use Disorders Identification Test) ≥8 = positive screening for any alcohol use disorder,≥16 = positive screening for a high-risk alcohol use disorder.</p></fn>
<fn id="table-fn7-0269216311409474">
<label>c</label>
<p>MSAS-SF (Memorial Symptom Assessment Scale-Short Form); total score (MSAS-SF total).</p></fn>
<fn id="table-fn8-0269216311409474">
<label>d</label>
<p>Global distress index (GDI).</p></fn>
<fn id="table-fn9-0269216311409474">
<label>e</label>
<p>Physical symptom subscale (PHYS).</p></fn>
<fn id="table-fn10-0269216311409474">
<label>f</label>
<p>Psychological symptom subscale (PSYCH).</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table6-0269216311409474" position="float">
<label>Table 6.</label>
<caption><p>Relationship between alcohol use disorders and anxiety (HADS-A ≥ 11) and Depression (HADS-D ≥ 11)</p></caption>
<graphic alternate-form-of="table6-0269216311409474" xlink:href="10.1177_0269216311409474-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">AUDIT &lt; 8 <italic>N</italic> = 98</th>
<th align="left">AUDIT ≥ 8<sup><xref ref-type="table-fn" rid="table-fn11-0269216311409474">a</xref></sup> <italic>N</italic> = 22</th>
<th align="left">Chi-square <italic>P</italic> value</th>
<th align="left">AUDIT &lt; 16 <italic>N</italic> = 113</th>
<th align="left">AUDIT ≥ 16<sup><xref ref-type="table-fn" rid="table-fn11-0269216311409474">b</xref></sup> <italic>N</italic> = 7</th>
<th align="left">Chi-square <italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td>HADS-A ≥ 11<sup><xref ref-type="table-fn" rid="table-fn12-0269216311409474">c</xref></sup></td>
<td>16 (89%)</td>
<td>2 (11%)</td>
<td rowspan="2" valign="top">0.38</td>
<td>17 (94%)</td>
<td>1 (6%)</td>
<td rowspan="2" valign="top">0.949</td>
</tr>
<tr>
<td>HADS-A &lt; 11</td>
<td>82 (80%)</td>
<td>20 (20%)</td>
<td>96 (94%)</td>
<td>6 (6%)</td>
</tr>
<tr>
<td>HADS-D ≥ 11<sup><xref ref-type="table-fn" rid="table-fn13-0269216311409474">d</xref></sup></td>
<td>24 (80%)</td>
<td>6 (20%)</td>
<td rowspan="2" valign="top">0.805</td>
<td>26 (87%)</td>
<td>4 (13%)</td>
<td rowspan="2" valign="top">0.045</td>
</tr>
<tr>
<td>HADS-D &lt; 11</td>
<td>74 (82%)</td>
<td>16 (18%)</td>
<td>86 (96%)</td>
<td>4 (4%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn11-0269216311409474">
<label>a, b</label>
<p>AUDIT (Alcohol Use Disorders Identification Test) ≥8 = positive screening for any alcohol use disorder, ≥16 = positive screening for a high-risk alcohol use disorder.</p></fn>
<fn id="table-fn12-0269216311409474">
<label>c</label>
<p>HADS-A (Hospital Anxiety and Depression Scale Anxiety score) ≥11 = positive screening for anxiety.</p></fn>
<fn id="table-fn13-0269216311409474">
<label>d</label>
<p>HADS-D (Hospital Anxiety and Depression Scale Depression score) ≥11 = positive screening for depression.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>There was no significant correlation between continuous AUDIT score and MSAS-SF total (<italic>r</italic> = 0.01) and subscale scores (GDI <italic>r</italic> = 0.1, PHYS <italic>r</italic> = 0.35, PSYCH <italic>r</italic> = 0.13) or HADS total (<italic>r</italic> = 0.05) and subscale scores (Hospital Anxiety and Depression Scale Depression score (HADS-D) <italic>r</italic> = 0.05, HADS-A <italic>r</italic> = 0.03).</p>
</sec>
<sec id="sectiontion7-0269216311409474" sec-type="discussion">
<title>Discussion</title>
<p>The prevalence of current alcohol use disorders in this population of cancer patients is 18%, and the prevalence of high-risk alcohol use disorders (harmful use or dependence) in this population is 6%. Previous North American retrospective studies have reported higher prevalence rates of lifetime alcohol dependence in palliative care advanced cancer patients (14%–38%).<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>–<xref ref-type="bibr" rid="bibr12-0269216311409474">12</xref></sup> Our study is not a direct comparison to these previous studies, as we have used a different screening method to detect a different cohort of alcohol problems. We used the AUDIT tool to screen for a range of current alcohol disorders (hazardous drinking, harmful use and dependence), whereas the majority of previous studies<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>–<xref ref-type="bibr" rid="bibr12-0269216311409474">12</xref></sup> utilized the Cut Down, Annoyed, Guilty and Eye Opener (CAGE) questionnaire,<sup><xref ref-type="bibr" rid="bibr21-0269216311409474">21</xref></sup> which is a validated four item screening tool for lifetime alcohol dependence only.<sup><xref ref-type="bibr" rid="bibr22-0269216311409474">22</xref>–<xref ref-type="bibr" rid="bibr24-0269216311409474">24</xref>,<xref ref-type="bibr" rid="bibr28-0269216311409474">28</xref></sup> The different screening methods used could account for the lower prevalence rate in our study thus implying a proportion of patients screening positively with the CAGE questionnaire in previous studies had a past medical history of alcohol dependence but were no longer actively drinking. Indeed, a number of subjects in our study commented that they did not enjoy, or could not tolerate, alcohol anymore.</p>
<p>This study demonstrates that the prevalence of current alcohol use disorders in this population of cancer patients (18%) is actually less than the general population of the UK (24%).<sup><xref ref-type="bibr" rid="bibr5-0269216311409474">5</xref></sup> There are a number of possible explanations for this, including demographic factors (the prevalence of alcohol use disorders decreases with age<sup><xref ref-type="bibr" rid="bibr5-0269216311409474">5</xref>,<xref ref-type="bibr" rid="bibr25-0269216311409474">25</xref></sup> and the mean age of subjects in our study was 61), changes in alcohol consumption relating to the diagnosis of cancer (i.e. lifestyle change), the effects of cancer (e.g. anorexia) and/or the effects of the cancer treatment (e.g. taste disturbance).</p>
<p>Interestingly, there was no association in this study between current alcohol use disorders and symptom distress in terms of individual physical or psychological symptom scores or validated physical and psychological symptom subscale scores. There was an association, however, between high-risk alcohol use disorders and a positive depression screening. Two previous studies assessed symptom scores in alcohol dependent patients in North America.<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>,<xref ref-type="bibr" rid="bibr12-0269216311409474">12</xref></sup> Parsons et al.<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref></sup> report that palliative care cancer patients with lifetime alcohol dependence (screened for by the CAGE questionnaire) have significantly higher pain, dyspnoea, sleep and well-being symptom scores compared with CAGE-negative patients, but there was no difference in anxiety and depression scores between groups. Bruera et al.<sup><xref ref-type="bibr" rid="bibr11-0269216311409474">11</xref></sup> report no significant differences in symptom intensity scores between CAGE-positive and negative advanced cancer patients in two separate cohorts.</p>
<p>General population data shows an increased risk of independent mood disorder in individuals with alcohol abuse or dependence,<sup><xref ref-type="bibr" rid="bibr26-0269216311409474">26</xref></sup> which supports the association reported in our study. The lack of association between anxiety and depression and lifetime alcohol dependence in other studies could reflect a less comprehensive screening method (single question on the Edmonton Symptom Assessment Scale as opposed to seven questions on the HADS) or indeed could imply that depression is associated with current alcohol dependence as opposed to lifetime alcohol dependence. The positive association between lifetime alcohol dependence, but not current alcohol use disorders or dependence, and certain physical symptoms in previous studies could reflect that such patients are at greater risk for chemical coping and somatization. This could be more associated with a predisposition best observed with lifetime behaviours rather than recent practice, thus not being demonstrated in our study. However, the lack of consensus data from previous studies using the CAGE screening tool means further evidence is needed before determining if such behaviours are associated.</p>
<p>Current smoking status was an independent predictor for all alcohol use disorders, including alcohol dependence. Male gender was an independent predictor for alcohol dependence only. This reflects UK general population data, where alcohol use disorders are more common in males, 38% compared to 15% in women,<sup><xref ref-type="bibr" rid="bibr5-0269216311409474">5</xref></sup> and in current smokers.<sup><xref ref-type="bibr" rid="bibr25-0269216311409474">25</xref></sup> It should be noted that the number of patients screening positively for alcohol dependence in this study was small, thus restricting our conclusions in this patient group. However, 57% of the patients with alcohol dependence in this study had an underlying diagnosis of head and neck cancer, which is unsurprising as alcohol is a major aetiological factor in the development of head and neck cancer in the western world.<sup><xref ref-type="bibr" rid="bibr4-0269216311409474">4</xref></sup></p>
<p>There were a number of limitations to this study. The patients were recruited from a specialist oncology centre and therefore may not be generalizable to other palliative care populations. Only seven patients screened positively for a high-risk alcohol use disorder, meaning results reported for this group of patients are subject to large degrees of error. Fifteen patients refused to participate in the study, mainly due to fatigue, however it is possible that such patients refused participation to avoid disclosure of alcohol problems, thus creating study bias. Previous research does, however, suggest that the majority of patients are not offended by discussing alcohol use, even if a disorder is present.<sup><xref ref-type="bibr" rid="bibr27-0269216311409474">27</xref></sup></p>
<p>As discussed previously, the majority of previous studies assessing alcohol dependence in palliative cancer populations used the CAGE questionnaire.<sup><xref ref-type="bibr" rid="bibr8-0269216311409474">8</xref>–<xref ref-type="bibr" rid="bibr12-0269216311409474">12</xref></sup> This is the first study to use the AUDIT tool to assess for alcohol use disorders in a cancer population. In retrospect the use of both screening methods in this study would have enabled more accurate comparisons to be made with published data, as well as comparisons between the two screening methods in this population.</p>
<p>In this study screening tools were used to detect the presence of alcohol use disorders, and depression and anxiety. Screening tools indicate the need for a more comprehensive assessment and are not diagnostic. There are recommended cut-off scores for the AUDIT and the HADS based on previous studies comparing the tools with psychiatric diagnoses.<sup><xref ref-type="bibr" rid="bibr14-0269216311409474">14</xref>,<xref ref-type="bibr" rid="bibr17-0269216311409474">17</xref></sup> However, there will always be false positive and negative results despite using optimal cut-offs. In this study we cannot comment on what proportion of positive screens represent true cases, only that results reported are based on patients with a higher likelihood of such disorders using validated screening tests.</p>
</sec>
<sec id="sectiontion8-0269216311409474" sec-type="conclusions">
<title>Conclusion</title>
<p>The results of this study suggest that current alcohol use disorders are no more common (and are probably less common) in patients with advanced cancer than the general population and there is no association between the presence of a current alcohol use disorder and physical and psychological symptoms. Depression is, however, associated with the presence of a high-risk alcohol use disorder and patients presenting with either of these problems should be screened for and assessed for the other.</p>
</sec>
</body>
<back>
<sec id="sectiontion9-0269216311409474">
<title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.</p>
</sec>
<sec id="sectiontion10-0269216311409474">
<title>Conflict of interest statement</title>
<p>None declared.</p>
</sec>
<sec id="sectiontion11-0269216311409474">
<title>Acknowledgements</title>
<p>We thank Yolanda Barbachano for statistical advice and Philippa Johnston for invaluable administrative support. This study provides the basis for an MSc in Palliative Medicine at the University of Bristol for the primary author.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0269216311409474">
<label>1.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>Lexicon of drug and alcohol terms</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>1994</year>.</citation>
</ref>
<ref id="bibr2-0269216311409474">
<label>2.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <article-title>Expert committee on problems related to alcohol consumption</article-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2007</year>.</citation>
</ref>
<ref id="bibr3-0269216311409474">
<label>3.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>International classification of diseases</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>10th revision Geneva WHO</publisher-name> <year>1992</year>.</citation>
</ref>
<ref id="bibr4-0269216311409474">
<label>4.</label>
<citation citation-type="book">
<collab>World Health Organization</collab>. <source>WHO global status report on alcohol</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr5-0269216311409474">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>McManus</surname><given-names>S</given-names></name>
<name><surname>Meltzer</surname><given-names>H</given-names></name>
<name><surname>Brugha</surname><given-names>T</given-names></name>
<name><surname>Bebbington</surname><given-names>P</given-names></name>
<name><surname>Jenkins</surname><given-names>R</given-names></name>
</person-group>. <source>The NHS Information Centre for Health and Social Care. Adult psychiatric morbidity in England</source>. <publisher-loc>London</publisher-loc>: <publisher-name>The NHS Information Centre</publisher-name>, <year>2007</year>.</citation>
</ref>
<ref id="bibr6-0269216311409474">
<label>6.</label>
<citation citation-type="book">
<collab>Department of Health</collab>. <source>Alcohol misuse: how much does it cost?</source>. <publisher-loc>London</publisher-loc>: <publisher-name>DOH</publisher-name>, <year>2003</year>.</citation>
</ref>
<ref id="bibr7-0269216311409474">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>BF</given-names></name>
<name><surname>Stinson</surname><given-names>FS</given-names></name>
<name><surname>Dawson</surname><given-names>DA</given-names></name>
<name><surname>Chou</surname><given-names>SP</given-names></name>
<name><surname>Dufour</surname><given-names>MC</given-names></name>
<name><surname>Compton</surname><given-names>W</given-names></name>
<etal/>
</person-group>. <article-title>Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions</article-title>. <source>Arch Gen Psychiatr</source> <year>2004</year>; <volume>61</volume>: <fpage>807</fpage>–<lpage>816</lpage>.</citation>
</ref>
<ref id="bibr8-0269216311409474">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>HA</given-names></name>
<name><surname>Delgado-Guay</surname><given-names>MO</given-names></name>
<name><surname>El Osta</surname><given-names>B</given-names></name>
<name><surname>Chacko</surname><given-names>R</given-names></name>
<name><surname>Poulter</surname><given-names>V</given-names></name>
<name><surname>Palmer</surname><given-names>JL</given-names></name>
<etal/>
</person-group>. <article-title>Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use</article-title>. <source>J Palliat Med</source> <year>2008</year>; <volume>11</volume>: <fpage>964</fpage>–<lpage>968</lpage>.</citation>
</ref>
<ref id="bibr9-0269216311409474">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jenkins</surname><given-names>CA</given-names></name>
<name><surname>Taube</surname><given-names>AW</given-names></name>
<name><surname>Turner</surname><given-names>K</given-names></name>
<name><surname>Hanson</surname><given-names>J</given-names></name>
<name><surname>Bruera</surname><given-names>E</given-names></name>
</person-group>. <article-title>Initial demographic, symptom, and medication profiles in patients admitted to continuing palliative care units</article-title>. <source>J Pain Symptom Manage</source> <year>1998</year>; <volume>16</volume>: <fpage>163</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr10-0269216311409474">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jenkins</surname><given-names>CA</given-names></name>
<name><surname>Schulz</surname><given-names>M</given-names></name>
<name><surname>Hanson</surname><given-names>J</given-names></name>
<name><surname>Bruera</surname><given-names>E</given-names></name>
</person-group>. <article-title>Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital</article-title>. <source>J Pain Symptom Manage</source> <year>2000</year>; <volume>19</volume>: <fpage>174</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr11-0269216311409474">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bruera</surname><given-names>E</given-names></name>
<name><surname>Moyano</surname><given-names>J</given-names></name>
<name><surname>Seifert</surname><given-names>L</given-names></name>
<name><surname>Fainsinger</surname><given-names>RL</given-names></name>
<name><surname>Hanson</surname><given-names>J</given-names></name>
<name><surname>Suarez-Almazor</surname><given-names>M</given-names></name>
</person-group>. <article-title>The frequency of alcoholism among patients with pain due to terminal cancer</article-title>. <source>JPain Symptom Manage</source> <year>1995</year>; <volume>10</volume>: <fpage>599</fpage>–<lpage>603</lpage>.</citation>
</ref>
<ref id="bibr12-0269216311409474">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bruera</surname><given-names>E</given-names></name>
<name><surname>Neumann</surname><given-names>C</given-names></name>
<name><surname>Brenneis</surname><given-names>C</given-names></name>
<name><surname>Quan</surname><given-names>H</given-names></name>
</person-group>. <article-title>Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals</article-title>. <source>JPalliat Care</source> <year>2000</year>; <volume>16</volume>: <fpage>16</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr13-0269216311409474">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bruera</surname><given-names>E</given-names></name>
<name><surname>Schoeller</surname><given-names>T</given-names></name>
<name><surname>Wenk</surname><given-names>R</given-names></name>
<name><surname>MacEachern</surname><given-names>T</given-names></name>
<name><surname>Marcelino</surname><given-names>S</given-names></name>
<name><surname>Hanson</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>A prospective multicenter assessment of the Edmonton staging system for cancer pain</article-title>. <source>J Pain Symptom Manage</source> <year>1995</year>; <volume>10</volume>: <fpage>348</fpage>–<lpage>355</lpage>.</citation>
</ref>
<ref id="bibr14-0269216311409474">
<label>14.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Babor</surname><given-names>T</given-names></name>
<name><surname>Higgins-Biddle</surname><given-names>J</given-names></name>
<name><surname>Saunders</surname><given-names>J</given-names></name>
<name><surname>Monteiro</surname><given-names>M</given-names></name>
</person-group>. <article-title>AUDIT: guidelines for use in primary care</article-title>. <edition>2nd ed.</edition> <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2001</year>.</citation>
</ref>
<ref id="bibr15-0269216311409474">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saunders</surname><given-names>JB</given-names></name>
<name><surname>Aasland</surname><given-names>OG</given-names></name>
<name><surname>Babor</surname><given-names>TF</given-names></name>
<name><surname>de la Fuente</surname><given-names>JR</given-names></name>
<name><surname>Grant</surname><given-names>M</given-names></name>
</person-group>. <article-title>Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II</article-title>. <source>Addiction</source> <year>1993</year>; <volume>88</volume>: <fpage>791</fpage>–<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr16-0269216311409474">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reinert</surname><given-names>DF</given-names></name>
<name><surname>Allen</surname><given-names>JP</given-names></name>
</person-group>. <article-title>The alcohol use disorders identification test: an update of research findings</article-title>. <source>Alcohol Clin Exp Res</source> <year>2007</year>; <volume>31</volume>: <fpage>185</fpage>–<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr17-0269216311409474">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zigmond</surname><given-names>AS</given-names></name>
<name><surname>Snaith</surname><given-names>RP</given-names></name>
</person-group>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source> <year>1983</year>; <volume>67</volume>: <fpage>361</fpage>–<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr18-0269216311409474">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le Fevre</surname><given-names>P</given-names></name>
<name><surname>Devereux</surname><given-names>J</given-names></name>
<name><surname>Smith</surname><given-names>S</given-names></name>
<name><surname>Lawrie</surname><given-names>SM</given-names></name>
<name><surname>Cornbleet</surname><given-names>M</given-names></name>
</person-group>. <article-title>Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12</article-title>. <source>Palliat Med</source> <year>1999</year>; <volume>13</volume>: <fpage>399</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr19-0269216311409474">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>VT</given-names></name>
<name><surname>Hwang</surname><given-names>SS</given-names></name>
<name><surname>Feuerman</surname><given-names>M</given-names></name>
<name><surname>Kasimis</surname><given-names>BS</given-names></name>
<name><surname>Thaler</surname><given-names>HT</given-names></name>
</person-group>. <article-title>The memorial symptom assessment scale short form (MSAS-SF)</article-title>. <source>Cancer</source> <year>2000</year>; <volume>89</volume>: <fpage>1162</fpage>–<lpage>1171</lpage>.</citation>
</ref>
<ref id="bibr20-0269216311409474">
<label>20.</label>
<citation citation-type="book">
<collab>SPSS for Windows, Rel</collab>. <year>2008</year>. <publisher-loc>Chicago, IL</publisher-loc>: <publisher-name>SPSS Inc</publisher-name>.</citation>
</ref>
<ref id="bibr21-0269216311409474">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayfield</surname><given-names>D</given-names></name>
<name><surname>McLeod</surname><given-names>G</given-names></name>
<name><surname>Hall</surname><given-names>P</given-names></name>
</person-group>. <article-title>The CAGE questionnaire: validation of a new alcoholism screening instrument</article-title>. <source>Am J Psychiatr</source> <year>1974</year>; <volume>131</volume>: <fpage>1121</fpage>–<lpage>1123</lpage>.</citation>
</ref>
<ref id="bibr22-0269216311409474">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>KA</given-names></name>
<name><surname>Kivlahan</surname><given-names>DR</given-names></name>
<name><surname>Bush</surname><given-names>KR</given-names></name>
<name><surname>McDonell</surname><given-names>Mb</given-names></name>
<name><surname>Fihn</surname><given-names>SD</given-names></name>
</person-group>. <article-title>Variations on the CAGE alcohol screening questionnaire: strengths and limitations in VA general medical patients</article-title>. <source>Alcohol Clin Exp Res</source> <year>2001</year>; <volume>25</volume>: <fpage>1472</fpage>–<lpage>1478</lpage>.</citation>
</ref>
<ref id="bibr23-0269216311409474">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>KA</given-names></name>
<name><surname>Bush</surname><given-names>KR</given-names></name>
<name><surname>McDonell</surname><given-names>MB</given-names></name>
<name><surname>Malone</surname><given-names>T</given-names></name>
<name><surname>Fihn</surname><given-names>SD</given-names></name>
</person-group>. <article-title>Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test</article-title>. <source>J Gen Intern Med</source> <year>1998</year>; <volume>13</volume>: <fpage>379</fpage>–<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr24-0269216311409474">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fiellin</surname><given-names>DA</given-names></name>
<name><surname>Reid</surname><given-names>MC</given-names></name>
<name><surname>O’Connor</surname><given-names>PG</given-names></name>
</person-group>. <article-title>Screening for alcohol problems in primary care: a systematic review</article-title>. <source>Arch Intern Med</source> <year>2000</year>; <volume>160</volume>: <fpage>1977</fpage>–<lpage>1989</lpage>.</citation>
</ref>
<ref id="bibr25-0269216311409474">
<label>25.</label>
<citation citation-type="book">
<collab>General Household Survey</collab>. <source>Smoking and drinking among adults, 2005</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Office National Statistics</publisher-name>, <year>2005</year>.</citation>
</ref>
<ref id="bibr26-0269216311409474">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>BF</given-names></name>
<name><surname>Dawson</surname><given-names>DA</given-names></name>
<name><surname>Stinson</surname><given-names>FS</given-names></name>
<name><surname>Chou</surname><given-names>SP</given-names></name>
<name><surname>Dufour</surname><given-names>MC</given-names></name>
<name><surname>Pickering</surname><given-names>RP</given-names></name>
</person-group>. <article-title>The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002</article-title>. <source>Drug Alcohol Depend</source> <year>2004</year>; <volume>74</volume>: <fpage>223</fpage>–<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr27-0269216311409474">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schermer</surname><given-names>CR</given-names></name>
<name><surname>Bloomfield</surname><given-names>LA</given-names></name>
<name><surname>Lu</surname><given-names>SW</given-names></name>
<name><surname>Demarest</surname><given-names>GB</given-names></name>
</person-group>. <article-title>Trauma patient willingness to participate in alcohol screening and intervention</article-title>. <source>J Trauma</source> <year>2003</year>; <volume>54</volume>: <fpage>701</fpage>–<lpage>706</lpage>.</citation>
</ref>
<ref id="bibr28-0269216311409474">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dhalla</surname><given-names>S</given-names></name>
<name><surname>Kopec</surname><given-names>JA</given-names></name>
</person-group>. <article-title>The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies</article-title>. <source>Clin Invest Med</source> <year>2007</year>; <volume>30</volume>: <fpage>33</fpage>–<lpage>41</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>